Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides
Open Access
- 1 January 2009
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 15 (15) , 1805-1808
- https://doi.org/10.3748/wjg.15.1805
Abstract
Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolidesKeywords
This publication has 8 references indexed in Scilit:
- Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and RibavirinGastroenterology, 2009
- Potential for Hepatitis C Virus Resistance to Nitazoxanide or TizoxanideAntimicrobial Agents and Chemotherapy, 2008
- Thiazolides: A New Class of Drugs for the Treatment of Chronic Hepatitis B and CFuture Microbiology, 2008
- Treatment of Chronic Hepatitis B (CHB) with Nitazoxanide (Ntz) Alone or Ntz Plus Adefovir (ADV) for Two Years with Loss of Hepatitis B E Antigen (HBeAg) and Hepatitis B Surface Antigen (HbsAg)American Journal of Gastroenterology, 2008
- Clinical trial: randomized, double‐blind, placebo‐controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4Alimentary Pharmacology & Therapeutics, 2008
- 832 EVALUATION OF A 4 WEEK LEAD-IN PHASE WITH NITAZOXANIDE PRIOR TO NITAZOXANIDE+PEGINTERFERON IN TREATING CHRONIC HEPATITIS CJournal of Hepatology, 2008
- Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replicationAntiviral Research, 2007
- NitazoxanideDrugs, 2007